FBLG Stock Summary and Trading Ideas (Fibrobiologics | NASDAQ:FBLG)

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

Fibrobiologics trades on the NASDAQ stock market under the symbol FBLG.

As of July 17, 2026, FBLG stock price declined to $0.83 with 149,350 million shares trading.

FBLG has a beta of -1.24, meaning it tends to be less sensitive to market movements. FBLG has a correlation of 0.01 to the broad based SPY ETF.

FBLG has a market cap of $5.08 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that FBLG belongs to (by Net Assets): VXF.

FBLG has underperformed the market in the last year with a price return of -94.0% while the SPY ETF gained +19.5%. FBLG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.4% and -4.6%, respectively, while the SPY returned +4.9% and -0.2%, respectively.

FBLG support price is $.79 and resistance is $.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBLG shares will trade within this expected range on the day.